Lineage switch in a pediatric patient with KMT2A-MLLT3 from acute megakaryoblastic leukemia to T cell acute lymphoblastic leukemia at the fourth relapse after allo-HSCT: with literature review

被引:0
|
作者
Li Gao
Jun Lu
Jie Li
Yixin Hu
Ye Lu
Weiwei Du
Shaoyan Hu
机构
[1] Children’s Hospital of Soochow University,Department of Hematology and Oncology
来源
关键词
Lineage switch; Acute megakaryoblastic leukemia; Relapse; T cell acute lymphoblastic leukemia;
D O I
暂无
中图分类号
学科分类号
摘要
We present a patient with acute megakaryoblastic leukemia (AMKL) harboring KMT2A-MLLT3 that converted to T cell acute lymphoblastic leukemia (T-ALL) at her fourth relapse. A 4-year-old girl developed AMKL with multiple swollen lymph nodes. She exhibited several recurrences in the bone marrow and died of septic shock after her fourth relapse. Bone marrow cells at the initial diagnosis and at all four relapses had the same KMT2A-MLLT3 fusion transcript. She also developed a somatic mutation (c.7177C > T p.Q2393X) of NOTCH1 at the fourth relapse. This sequential phenotypic and cytogenetic study may yield valuable insights into the mechanism of AMKL to T-ALL lineage switch and possible implications for treatment selection.
引用
收藏
页码:781 / 785
页数:4
相关论文
共 50 条
  • [41] Bone marrow leukemic progenitor cell content in pediatric T-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse
    Uckun, FM
    Gaynon, PS
    Stram, DO
    Sensel, MG
    Sarquis, MB
    Willoughby, M
    LEUKEMIA & LYMPHOMA, 2001, 40 (3-4) : 279 - 285
  • [42] FLT3 chimeric antigen receptor T cell therapy induces B to T cell lineage switch in infant acute lymphoblastic leukemia
    Chien, Christopher D.
    Yang, Lila
    Nguyen, Sang M.
    Sauter, Christopher T.
    Ishii, Kazusa
    Shen, Feng
    Tasian, Sarah K.
    Fry, Terry J.
    CANCER RESEARCH, 2018, 78 (13)
  • [43] Umbilical cord blood transplantation can overcome the poor prognosis of KMT2A-MLLT3 acute myeloid leukemia and can lead to good GVHD-free/relapse-free survival
    Tong, Juan
    Zhang, Lei
    Liu, Huilan
    Xu, Xiucai
    Zheng, Changcheng
    Yao, Wen
    Zhu, Xiaoyu
    Tang, Baolin
    Wan, Xiang
    Song, Kaidi
    Zhang, Xuhan
    Sun, Guangyu
    Sun, Zimin
    ANNALS OF HEMATOLOGY, 2021, 100 (05) : 1303 - 1309
  • [44] Therapy-induced Deletion in 11q23 Leading to Fusion of KMT2A With ARHGEF12 and Development of B Lineage Acute Lymphoplastic Leukemia in a Child Treated for Acute Myeloid Leukemia Caused by t(9;11)( p21;q23)/KMT2A-MLLT3
    Panagopoulos, Ioannis
    Andersen, Kristin
    Eilert-Olsen, Martine
    Zeller, Bernward
    Munthe-Kaas, Monica Cheng
    Buechner, Jochen
    Osnes, Liv T. N.
    Micci, Francesca
    Heim, Sverre
    CANCER GENOMICS & PROTEOMICS, 2021, 18 (01) : 67 - 81
  • [45] Myosin 1g as a high-risk biomarker in a pediatric patient with lineage switch from acute lymphoblastic leukemia to myeloid phenotype
    Araujo-Cardenas, Janeth E.
    Rodriguez-Ruiz, Miguel A.
    Lopez-Valdez, Jaime A.
    Rodriguez-Tellez, Rosa I.
    Garfias-Gomez, Yanelly
    Parra-Ortega, Israel
    Patino-Lopez, Genaro
    BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2023, 80 (02): : 135 - 143
  • [46] Umbilical cord blood transplantation can overcome the poor prognosis of KMT2A-MLLT3 acute myeloid leukemia and can lead to good GVHD-free/relapse-free survival
    Juan Tong
    Lei Zhang
    Huilan Liu
    Xiucai Xu
    Changcheng Zheng
    Wen Yao
    Xiaoyu Zhu
    Baolin Tang
    Xiang Wan
    Kaidi Song
    Xuhan Zhang
    Guangyu Sun
    Zimin Sun
    Annals of Hematology, 2021, 100 : 1303 - 1309
  • [47] Lineage switch to acute myeloid leukemia during induction chemotherapy for early T-cell precursor acute lymphoblastic leukemia with the translocation t(6;11)(q27;q23)/KMT2A-AFDN: A case report
    Permikin, Zhan
    Popov, Alexander
    Verzhbitskaya, Tatiana
    Riger, Tatiana
    Plekhanova, Olga
    Makarova, Olga
    Fronkova, Eva
    Trka, Jan
    Meyer, Claus
    Marschalek, Rolf
    Tsaur, Grigory
    Fechina, Larisa
    LEUKEMIA RESEARCH, 2022, 112
  • [48] KMT2A-MLLT1 and the Novel SEC16A-KMT2A in a Cryptic 3-Way Translocation t(9;11;19) Present in an Infant With Acute Lymphoblastic Leukemia
    de Matos, Roberto R. C.
    Ferreira, Gerson M.
    Meyer, Claus
    Marschalek, Rolf
    Larghero, Patrizia
    Ribeiro, Raul C.
    Liehr, Thomas
    Othman, Moneeb
    Bizarro, Mariana T. de S. M.
    da Costa, Elaine Sobral
    Land, Marcelo G. P.
    Abdelhay, Eliana
    Binato, Renata
    Silva, Maria Luiza M.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2022, 44 (03) : E719 - E722
  • [49] Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in KMT2A-rearranged acute lymphoblastic leukemia: a case report and review of the literature
    Fournier, Elise
    Inchiappa, Luca
    Delattre, Carole
    Pignon, Jean-Michel
    Danicourt, Frederique
    Bemba, Maxime
    Roche-Lestienne, Catherine
    Daudignon, Agnes
    Decool, Gauthier
    Roumier, Christophe
    Dumezy, Florent
    Fournier, Loic
    Grardel, Nathalie
    Preudhomme, Claude
    Duployez, Nicolas
    LEUKEMIA & LYMPHOMA, 2019, 60 (07) : 1827 - 1830
  • [50] Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: Case report and review of the literature
    Reichard, KK
    Zhang, QY
    Sanchez, L
    Hozier, J
    Viswanatha, D
    Foucar, K
    AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (03) : 178 - 185